Related Experiment Video
Updated: May 16, 2026

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
Published on: June 10, 2025
Ancillary testing, diagnostic/classification criteria and severity grading in Behçet disease
Annabelle A Okada1, Miles Stanford, Khalid Tabbara
1Kyorin Eye Center, Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan. aokada@eye-center.org
Diagnosing Behçet disease relies on characteristic clinical findings, as no single test exists. Ancillary tests and classification criteria aid in assessing severity and guiding treatment for this complex uveitic condition.
Area of Science:
- Ophthalmology
- Rheumatology
- Immunology
Background:
- Behçet disease diagnosis lacks a definitive clinical sign or lab test.
- Distinguishing Behçet disease from other uveitic conditions is challenging.
- Diagnosis relies on characteristic ocular and systemic findings, excluding other causes.
Purpose of the Study:
- To review diagnostic approaches for Behçet disease.
- To highlight the role of ancillary tests in managing Behçet disease.
- To discuss current classification criteria and severity grading schemes.
Main Methods:
- Review of diagnostic criteria for Behçet disease.
- Assessment of ancillary tests in evaluating ocular and systemic involvement.
- Examination of proposed grading schemes for ocular disease severity.
Main Results:
- Diagnosis is clinical, based on a constellation of findings.
- Ancillary tests (imaging) assess disease severity and monitor treatment.
- Two main classification criteria sets are widely used by clinicians.
Conclusions:
- Behçet disease diagnosis requires careful evaluation of clinical manifestations.
- Ancillary tests are crucial for comprehensive disease assessment and management.
- Standardized criteria and grading schemes aid in consistent diagnosis and treatment monitoring.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Heart Failure IV: Classification and Diagnostic Evaluation
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...

